
A startup in France is leveraging artificial intelligence-backed physics principles in the hope of speeding up the process of making new drugs.
Currently, developing a new medicine takes a company 10 to 15 years on average, with research conducted in a lab environment – and a lot of trial and error before they enter multiple stages of human clinical trials.